Search

Displaying results 8211 - 8220 of 10000 in total
  1. Drug

    Etozoline

    go.drugbank.com/drugs/DB08982
    Experimental

    Etozoline is marketed in Europe under the names Diulozin, Elkapin, and Etopinil. Etozoline is a loop diuretic.

  2. Drug

    Vatalanib

    go.drugbank.com/drugs/DB04879
    Investigational

    Vatalanib is under investigation for the treatment of solid tumors. … Vatalanib (PTK787/ZK-222584) is a new oral antiangiogenic molecule that inhibits all known vascular endothelial growth factor receptors.

  3. Drug

    HTPEP-001

    go.drugbank.com/drugs/DB18730
    Experimental

    HTPEP-001 is a novel peptide that works to inhibit the activation of transforming growth factor beta (TGF-β). It is being investigated for the treatment of fibrosis.[A263527]

  4. Drug

    VH4367310

    go.drugbank.com/drugs/DB33961
    Experimental

    VH4367310 is a small molecule drug. … VH4367310 is under investigation in clinical trial NCT07818915 (A Study to Investigate Pharmacokinetics (PK), Safety, and Tolerability of VH4367310 in Healthy Adult Participants).

  5. Drug

    Aetiocholanolone

    go.drugbank.com/drugs/DB02854
    Experimental

    Etiocholanolone is a major metabolite of testosterone and androstenedione in many mammalian species including humans. It is excreted in the urine. [PubChem]

  6. Drug

    Narasin

    go.drugbank.com/drugs/DB11432
    ExperimentalVet approved

    Narasin is an agent with coccidiostatic and antibacterial properties.

  7. Drug

    MK-4965

    go.drugbank.com/drugs/DB08460
    Experimental

    MK-4965 is an HIV-1 reverse transcriptase inhibitor.

  8. Drug

    Estrane-3,17-dione

    go.drugbank.com/drugs/DB04693
    Experimental

    Estrane-3,17-dione is a potent inhibitor of isomerase.

  9. Drug

    Azoxystrobin

    go.drugbank.com/drugs/DB07401
    Experimental

    Azoxystrobin is a methoxyacrylate analog and a strobilurin fungicide.

    Categories: Electron Transport Complex III
  10. Drug

    PD-168393

    go.drugbank.com/drugs/DB07662
    Experimental

    PD-168393 is an epidermal growth factor receptor inhibitor.